In situ tumour arrays reveal early environmental control of cancer immunity
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The immune phenotype of a tumour is a key predictor of its response to immunotherapy 1–4. Patients who respond to checkpoint blockade generally present with immune-inflamed 5–7 tumours that are highly infiltrated by T cells. However, not all inflamed tumours respond to therapy, and even lower response rates occur among tumours that lack T cells (immune desert) or that spatially exclude T cells to the periphery of the tumour lesion (immune excluded)8. Despite the importance of these tumour immune phenotypes in patients, little is known about their development, heterogeneity or dynamics owing to the technical difficulty of tracking these features in situ. Here we introduce skin tumour array by microporation (STAMP)—a preclinical approach that combines high-throughput time-lapse imaging with next-generation sequencing of tumour arrays. Using STAMP, we followed the development of thousands of arrayed tumours in vivo to show that tumour immune phenotypes and outcomes vary between adjacent tumours and are controlled by local factors within the tumour microenvironment. Particularly, the recruitment of T cells by fibroblasts and monocytes into the tumour core was supportive of T cell cytotoxic activity and tumour rejection. Tumour immune phenotypes were dynamic over time and an early conversion to an immune-inflamed phenotype was predictive of spontaneous or therapy-induced tumour rejection. Thus, STAMP captures the dynamic relationships of the spatial, cellular and molecular components of tumour rejection and has the potential to translate therapeutic concepts into successful clinical strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two recent systematic evaluations of more than 15 cell-cell communication inference methods suggest CellChat is among the top-performing methods 21,28 .”
From CellChat for systematic analysis of cell–cell communication from single-cell transcriptomics (2025) · cites this paper as [28]
In the citing paper
“Numerous computational tools have been developed to facilitate cell-cell communication exploration and analysis”
From CellChat for systematic analysis of cell–cell communication from single-cell transcriptomics (2025) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inference and analysis of cell-cell communication using CellChat
Jin, S., Guerrero-Juarez, C. F., Zhang, L., Chang, I., Ramos, R., Kuan, C.-H., Myung, P., Plikus, M. V., & Nie, Q. (2021) · Nature Communications · doi:10.1038/s41467-021-21246-9 · Cited by 8,409
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Spranger, S., Bao, R., & Gajewski, T. F. (2015) · Nature · doi:10.1038/nature14404 · Cited by 2,830
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Tauriello, D. V. F., Palomo-Ponce, S., Stork, D., Berenguer-Llergo, A., Badia-Ramentol, J., Iglesias, M., Sevillano, M., Ibiza, S., Cañellas, A., Hernando-Momblona, X., et al. (2018) · Nature · doi:10.1038/nature25492 · Cited by 1,851
Predictive biomarkers for checkpoint inhibitor-based immunotherapy
Gibney, G. T., Weiner, L. M., & Atkins, M. B. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30406-5 · Cited by 1,635
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586
Clustering trees: a visualization for evaluating clusterings at multiple resolutions
Zappia, L., & Oshlack, A. (2018) · GigaScience · doi:10.1093/gigascience/giy083 · Cited by 1,064
Dominguez, C. X., Müller, S., Keerthivasan, S., Koeppen, H., Hung, J., Gierke, S., Breart, B., Foreman, O., Bainbridge, T. W., Castiglioni, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0644 · Cited by 857
Self-citationIL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines
Tahtinen, S., Tong, A.-J., Himmels, P., Oh, J., Paler-Martinez, A., Kim, L., Wichner, S., Oei, Y., McCarron, M. J., Freund, E. C., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01160-y · Cited by 535
Self-citation
Research works printed but not linked: 34
- Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer–immune set point. Nature 541, 321–330 (2017). · DOI · Paper page
- Galon, J. & Bruni, D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat. Rev. Drug Discov. 18, 197–218 (2019). · DOI · Paper page
- Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960–1964 (2006). · DOI · Paper page
- Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568–571 (2014). · DOI · Paper page
- Herbst, R. S. et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 515, 563–567 (2014). · DOI · Paper page
- Gajewski, T. F. The next hurdle in cancer immunotherapy: overcoming the non-T-cell-inflamed tumor microenvironment. Semin. Oncol. 42, 663–671 (2015). · DOI · Paper page
- Bachhav, Y. G., Heinrich, A. & Kalia, Y. N. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology. Eur. J. Pharm. Biopharm. 84, 355–364 (2013). · DOI
- Chung, W.-J. et al. Kras mutant genetically engineered mouse models of human cancers are genomically heterogeneous. Proc. Natl Acad. Sci. USA 114, E10947–E10955 (2017).
- Mariathasan, S. et al. TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554, 544–548 (2018). · DOI · Paper page
- Desbois, M. et al. Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer. Nat. Commun. 11, 5583 (2020). · DOI · Paper page
- Spranger, S. & Gajewski, T. F. Impact of oncogenic pathways on evasion of antitumour immune responses. Nat. Rev. Cancer 18, 139–147 (2018). · DOI · Paper page
- Liu, X. & Peng, G. Mitochondria orchestrate T cell fate and function. Nat. Immunol. 22, 276–278 (2021). · DOI
- Buck, M. D. et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell 166, 63–76 (2016). · DOI · Paper page
- Li, W. & Zhang, L. Rewiring mitochondrial metabolism for CD8+ T cell memory formation and effective cancer immunotherapy. Front. Immunol. 11, 1834 (2020). · DOI
- Araki, K. et al. Translation is actively regulated during the differentiation of CD8+ effector T cells. Nat. Immunol. 18, 1046–1057 (2017). · DOI · Paper page
- Chen, T.-W. et al. Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature 499, 295–300 (2013). · DOI · Paper page
- Buechler, M. B. et al. Cross-tissue organization of the fibroblast lineage. Nature 593, 575–579 (2021). · DOI · Paper page
- Tavernari, D. et al. Nongenetic evolution drives lung adenocarcinoma spatial heterogeneity and progression. Cancer Discov. 11, 1490–1507 (2021). · DOI
- Angelova, M. et al. Evolution of metastases in space and time under immune selection. Cell 175, 751–765 (2018). · DOI · Paper page
- Doerr, J. et al. Whole-brain 3D mapping of human neural transplant innervation. Nat. Commun. 8, 14162 (2017). · DOI
- Geraldo, S., Simon, A. & Vignjevic, D. M. Revealing the cytoskeletal organization of invasive cancer cells in 3D. J. Vis. Exp. https://doi.org/10.3791/50763 (2013). · doi:10.3791/50763
- Helou, S. M. et al. A relationship-based approach to improving clinical trials: the imCORE research network experience. Contemp. Clin. Trials 86, 105861 (2019). · doi:10.1016/j.cct.2019.105861
- Powles, T. et al. Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial. Nat. Med. 25, 1706–1714 (2019). · DOI · Paper page
- Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25, 1754–1760 (2009). · DOI · Paper page
- DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491–498 (2011). · DOI · Paper page
- Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs. Bioinformatics 28, 1811–1817 (2012). · DOI · Paper page
- Huber, W. et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat. Methods 12, 115–121 (2015). · DOI · Paper page
- Frankish, A. et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 47, gky955 (2018).
- Fontes, M. & Soneson, C. The projection score—an evaluation criterion for variable subset selection in PCA visualization. BMC Bioinform. 12, 307 (2011). · DOI
- Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).
- Liberzon, A. et al. The Molecular Signatures Database hallmark gene set collection. Cell Syst. 1, 417–425 (2015). · DOI · Paper page
- Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018). · DOI · Paper page
- Henningsson, R., Moratorio, G., Bordería, A. V., Vignuzzi, M. & Fontes, M. DISSEQT—distribution-based modeling of SEQuence space time dynamics. Virus Evol. 5, vez028 (2019). · DOI
- Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847–2849 (2016). · DOI · Paper page
Cited by
CellChat for systematic analysis of cell–cell communication from single-cell transcriptomics
Jin, S., Plikus, M. V., & Nie, Q. (2025) · Nature Protocols · doi:10.1038/s41596-024-01045-4 · Cited by 1,448
“CellChat has been used to predict a new role for a unique subset of cancer-associated fibroblasts in recruiting monocytes and neutrophils using in situ tumor arrays 28 .”
The cancer-immunity cycle: Indication, genotype, and immunotype
Mellman, I., Chen, D. S., Powles, T., & Turley, S. J. (2023) · Immunity · doi:10.1016/j.immuni.2023.09.011 · Cited by 953
Self-citationGao, Y., Li, J., Cheng, W., Diao, T., Liu, H., Bo, Y., Liu, C., Zhou, W., Chen, M., Zhang, Y., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.08.020 · Cited by 285
Metadata
- Authors
- Ortiz-Muñoz, G., Brown, M., Carbone, C. B., Pechuan-Jorge, X., Rouilly, V., Lindberg, H., Ritter, A. T., Raghupathi, G., Sun, Q., Nicotra, T., Mantri, S. R., Yang, A., Doerr, J., Nagarkar, D., Darmanis, S., Haley, B., Mariathasan, S., Wang, Y., Gomez-Roca, C., de Andrea, C. E., Spigel, D., Wu, T., Delamarre, L., Schöneberg, J., Modrusan, Z., Price, R., Turley, S. J., Mellman, I., & Moussion, C.
- ORCID
- Venue
- Nature
- Published
- 2023-05-31
- Volume
- 618
- Issue
- 7966
- Pages
- 827-833
- ISSN
- 0028-0836
- 1476-4687
- Cited by
- 53
- References
- 8
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In situ tumour arrays reveal early environmental control of cancer immunity. https://app.cochat.ai/papers/10.1038/s41586-023-06132-2
- The paper
- Ortiz-Muñoz, G., Brown, M., Carbone, C. B., Pechuan-Jorge, X., Rouilly, V., Lindberg, H., Ritter, A. T., Raghupathi, G., Sun, Q., Nicotra, T., Mantri, S. R., Yang, A., Doerr, J., Nagarkar, D., Darmanis, S., Haley, B., Mariathasan, S., Wang, Y., Gomez-Roca, C., . . . Moussion, C. (2023). In situ tumour arrays reveal early environmental control of cancer immunity. Nature. https://doi.org/10.1038/s41586-023-06132-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.